Jul 11 |
AIM ImmunoTech files to sell 11.28M shares of common stock for holders
|
Jun 10 |
AIM ImmunoTech to Participate in the Virtual Investor Pitch Conference
|
Jun 3 |
AIM ImmunoTech to Participate in the Virtual Investor Lunch Break Series
|
May 31 |
AIM ImmunoTech announces pricing of $2.0M registered direct offering
|
May 31 |
AIM ImmunoTech Announces Pricing of $2.0 Million Registered Direct Offering
|
May 16 |
AIM ImmunoTech Inc. (AIM) Q1 2024 Earnings Call Transcript
|
May 16 |
AIM ImmunoTech GAAP EPS of -$0.12
|
May 16 |
AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate Update
|
May 15 |
AIM ImmunoTech Q1 2024 Earnings Preview
|
May 6 |
AIM ImmunoTech Completes cGMP Manufacturing of Clinical Vials of Ampligen®
|